Pfizer beat earnings but here’s why this analyst downgraded the stock to neutral
May 06, 2021 at 08:16 AM EDT
Mizuho Securities says the pharma giant needs its pipeline to deliver for investors to gain more comfort with Pfizer's outlook.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|